The worldwide market for Microbiome Therapeutics is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in

Major Region

s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
OpenBiome
Synthetic Biologics
AgBiome
C3 Jian
ActoGeniX
Admera Health
Advanced Technology Ventures
Avid Biotics
Immuron
AbbVie
Osel
Assembly Biosciences
Second Genome
MicroBiome Therapeutics
Advancing Bio
AOBiome
4D Pharma
APC Microbiome Institute
Enterome Bioscience
Azitra
Seres Therapeutics
Ritter Pharmaceuticals


Major Types Covered
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Inulin

Major Applications Covered
Antibiotic-Associated Diarrhoea (AAD)
Infectious Childhood Diarrhoea
Cholesterol
Inflammatory Bowel Disease (IBD)
Blood Pressure
Lactose Intolerance
Weight Loss
Vitamin Production
Bacterial Vaginosis (BV)
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…

Years considered for this report:

Historical Years:

2014-2018

Base Year:

2019

Estimated Year:

2019

Forecast Period:

2019-2026